RE: My worst investment of all time.4 Apr 2022 09:55
Unfortunately like any investment it depends on timing. I have averaged down to sub 5p now. It’s been hard work!
Re funding the P1 GaM trial is sponsored which is fully funded. We know from the RNS and the tweets.
As far as IB goes that ‘should’ be self funded based on the known revenues and grants…..
‘ we saw a step-change increase in revenue and completed our most successful year on record; more than doubling revenue to nearly $700K. While we continue to receive funding from the National Institutes of Health (NIH) for various grant activities, this marked increase was driving by growth in sales of IB Clinic-container edition (IB-ce). In addition to record sales, we continued to receive strong activity for trial requests of IB software. Most of these requests were for IB-ce, which enables fully automated generation of our quantitative parameter maps. We are the only company in the world with this capability and, given that IB-ce was introduced only a few short years ago, we are extremely encouraged with the initial adoption rate. …..etc”
So for all intensive purposes this is ticking along under its own steam.
Regarding the other tech, stonechecker and the other IB suite I think that’s on ice whilst the aforementioned projects are matured.
However, the lack of updates that may drive the exit spike that many hope for is well overdue.
All said a bigger contract, JV or sale of IB could massively rerate this lowly mcap. Holders will know that one cannot rule out a US buyer. It happened at Lidco last year. There is an appetite for this tech. We know that from the contracts and USP of the product. We know our closest peer POLX is worth much more!
Don’t you just love FOMO hey! Should I stay or should I go now. If I go it will more than double and if I stay there will likely be trouble! Lol!
All I can say is if you are nervous don’t be greedy. But don’t miss out!
Usual caveats
Trek